CXCR2 and cystic fibrosis: Some compounds have already been tested in patients [for example, CXCR2 antagonists to block neutrophil chemotaxis in cystic fibrosis (333) and a neutrophil elastase inhibitor in acute lung injury (247)] with limited success.